Oxford's COVID-19 Vaccine Volunteer Dies; Trials Process Unaffected

A 28-year-old volunteer from Brazil has died during the clinical trials of the COVID-19 vaccine developed by the Oxford University and AstraZeneca. However, the Oxford has clarified that the trials will be continued, and said, "there have been no concerns about the safety of the clinical trial." According to Reuters, the volunteer was given a 'meningitis vaccine' and not a COVID-19 vaccine. Following the news, AstraZeneca's shares fell 1.8%.